Newly Initiated: Multiple-Ascending Dose Portion of KAN-101 Trial for Celiac Disease
Source: pixabay.com

Newly Initiated: Multiple-Ascending Dose Portion of KAN-101 Trial for Celiac Disease

  During the drug development process, multiple studies are performed to evaluate efficacy, safety, tolerability, pharmacokinetics, and other factors. One of these studies is called a multiple ascending dose study, during which…

Continue Reading Newly Initiated: Multiple-Ascending Dose Portion of KAN-101 Trial for Celiac Disease